静息13N-氨PET心肌血流量预测CABG后心肌存活与心室功能恢复
静息心肌血流量识别存活心肌的最佳 cut-off 为0.42 ml/min/g(敏感度88.3%,特异度82.0%),预测CABG后LVEF改善≥8%的最佳 cut-off 为0.43 ml/min/g(74.6%,80.0%)。静息MBF可作为18F-FDG PET的补充用于评估存活心肌和预测CABG后LVEF改善。
要点
- 静息MBF识别存活心肌 cut-off 0.42 ml/min/g,敏感度88.3%、特异度82.0%。
- 静息MBF预测CABG后LVEF改善≥8% cut-off 0.43 ml/min/g,敏感度74.6%、特异度80.0%。
- 各灌注/代谢模式间静息MBF均值差异显著(P<0.001)。
核心结论
- 动态13N-氨PET获得的静息MBF可作为18F-FDG PET的补充,用于评估存活心肌并预测CABG后LVEF的潜在改善。
研究设计与样本
- 将灌注/代谢极坐标图分为正常(N)、不匹配(M1)、匹配(M2)和反向不匹配(RM)四种模式。
- 采用ROC曲线分析静息MBF识别存活心肌(M1、RM)及预测CABG后LVEF改善≥8%的价值。
主要发现
- 各模式静息MBF均值分别为N=0.60±0.14、M1=0.44±0.07、M2=0.34±0.08、RM=0.53±0.09 ml/min/g,差异有统计学意义(P<0.001)。
- 联合M1/RM的范围与静息MBF同CABG后LVEF改善呈中至高度相关(r=0.78、0.71,P<0.001)。
关键数值与推荐
- 识别存活心肌的最佳静息MBF cut-off为0.42 ml/min/g,敏感度88.3%、特异度82.0%。
- 预测CABG后LVEF改善≥8%的最佳静息MBF cut-off为0.43 ml/min/g,敏感度74.6%、特异度80.0%。
临床怎么用
- 对拟行CABG的冠心病伴慢性LVEF<45%患者,可结合动态13N-氨PET静息MBF与18F-FDG PET评估存活心肌。
- 静息MBF高于约0.42–0.43 ml/min/g提示存活心肌可能性大及CABG后LVEF改善潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to evaluate the feasibility of resting myocardial blood flow (rMBF), quantified with dynamic 13 N-Ammonia (NH3) PET, for identifying myocardial viability and predicting improvement of left ventricular ejection fraction (LVEF) after coronary artery bypass grafting (CABG). METHODS: Ninety-three patients with coronary artery disease (CAD) and chronic LVEF < 45%, scheduled for CABG, had dynamic 13NH3 PET and 18F-FDG PET imaging. The perfusion/metabolism polar maps were categorized in four patterns: normal (N), mismatch (M1), match (M2) and reverse mismatch (RM). The value of rMBF for identifying viable myocardium (M1, RM) and post CABG improvement of LVEF≥8% was analyzed by receiver operating characteristic (ROC) curves. Correlations of rMBF in segments to ΔLVEF post CABG were verified. RESULTS: Mean rMBFs were significantly different (N=0.60±0.14; M1=0.44±0.07, M2=0.34±0.08, RM=0.53±0.09 ml/min/g, P<0.001). The optimal rMBF cutoff to identify viable myocardium was 0.42 ml/min/g (sensitivity=88.3%, specificity=82.0%) and 0.43 ml/min/g for predicting improvement of LVEF ≥8% (74.6%, 80.0%). The extent and rMBF of combined M1/RM demonstrated a moderate to high correlation to improved LVEF (r=0.78, 0.71, P<0.001). CONCLUSION: Resting MBF, derived by dynamic 13NH3 PET, may be positioned as a supplement to 18F-FDG PET imaging for assessing the presence of viable myocardium and predicting potential improvement of LVEF after CABG.
引用
- Wang J, Li JM, Li S, et al. Absolute Resting 13N-Ammonia PET Myocardial Blood Flow for Predicting Myocardial Viability and Recovery of Ventricular Function after Coronary Artery Bypass Grafting. J Nucl Cardiol. 2020. PMID: 33089879. doi:10.1007/s12350-020-02388-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。